Merck Kgaa Adr Stock Price To Earning
| MKKGY Stock | USD 36.31 0.30 0.82% |
Merck KGaA ADR fundamentals help investors to digest information that contributes to Merck KGaA's financial success or failures. It also enables traders to predict the movement of Merck Pink Sheet. The fundamental analysis module provides a way to measure Merck KGaA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Merck KGaA pink sheet.
Merck |
Merck KGaA ADR Company Price To Earning Analysis
Merck KGaA's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current Merck KGaA Price To Earning | 33.17 X |
Most of Merck KGaA's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Merck KGaA ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, Merck KGaA ADR has a Price To Earning of 33.17 times. This is 28.37% higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The price to earning for all United States stocks is 15.49% lower than that of the firm.
Merck Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Merck KGaA's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Merck KGaA could also be used in its relative valuation, which is a method of valuing Merck KGaA by comparing valuation metrics of similar companies.Merck KGaA is currently under evaluation in price to earning category among related companies.
Merck Fundamentals
| Return On Equity | 0.14 | |||
| Return On Asset | 0.0656 | |||
| Profit Margin | 0.16 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 92.22 B | |||
| Shares Outstanding | 2.17 B | |||
| Shares Owned By Institutions | 0.03 % | |||
| Price To Earning | 33.17 X | |||
| Price To Book | 2.75 X | |||
| Price To Sales | 3.86 X | |||
| Revenue | 19.69 B | |||
| Gross Profit | 12.36 B | |||
| EBITDA | 5.95 B | |||
| Net Income | 3.06 B | |||
| Cash And Equivalents | 1.71 B | |||
| Cash Per Share | 0.79 X | |||
| Total Debt | 7.93 B | |||
| Debt To Equity | 0.45 % | |||
| Current Ratio | 1.28 X | |||
| Book Value Per Share | 12.98 X | |||
| Cash Flow From Operations | 4.62 B | |||
| Earnings Per Share | 1.72 X | |||
| Price To Earnings To Growth | 3.07 X | |||
| Target Price | 44.0 | |||
| Number Of Employees | 63.72 K | |||
| Beta | 0.65 | |||
| Market Capitalization | 88.17 B | |||
| Total Asset | 45.36 B | |||
| Z Score | 6.6 | |||
| Annual Yield | 0.01 % | |||
| Five Year Return | 1.14 % | |||
| Net Asset | 45.36 B | |||
| Last Dividend Paid | 1.85 |
About Merck KGaA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Merck KGaA ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Merck KGaA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Merck KGaA ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merck KGaA ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Merck KGaA ADR information on this page should be used as a complementary analysis to other Merck KGaA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Complementary Tools for Merck Pink Sheet analysis
When running Merck KGaA's price analysis, check to measure Merck KGaA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck KGaA is operating at the current time. Most of Merck KGaA's value examination focuses on studying past and present price action to predict the probability of Merck KGaA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck KGaA's price. Additionally, you may evaluate how the addition of Merck KGaA to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |